NCT05965440View on ClinicalTrials.gov

Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived from the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

May 20, 2025

Study Completion Date

August 20, 2025

Conditions
Chronic Kidney Diseases
Interventions
DRUG

impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients

Analysis of microbiota

Trial Locations (1)

Unknown

RECRUITING

Nephrology department, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER